Vaccines, blood, antisera, toxins and cultures in   Zambia

Exports In 2022, Zambia exported $1.31M in Vaccines, blood, antisera, toxins and cultures, making it the 103rd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 176th most exported product in Zambia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Zambia are: Equatorial Guinea ($1.27M), Zimbabwe ($22k), Democratic Republic of the Congo ($5.89k), Angola ($5.49k), and India ($3.62k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Zambia between 2021 and 2022 were Equatorial Guinea ($1.27M), Zimbabwe ($22k), and Democratic Republic of the Congo ($5.89k).

Imports In 2022, Zambia imported $205M in Vaccines, blood, antisera, toxins and cultures, becoming the 78th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 12th most imported product in Zambia. Zambia imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($79.5M), Equatorial Guinea ($40.4M), United States ($29.4M), India ($14.8M), and Italy ($12.8M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Zambia between 2021 and 2022 were Belgium ($67.7M), Equatorial Guinea ($40.4M), and United States ($17.7M).